IL22ra2 is an antagonist of IL22, and its levels are down-regulated in the inflamed colon18 but up-regulated in human atopic dermatitis and psoriasis lesions in clinical remission19 and IL22ra2 has been implicated in suppressing inflammation.20 The gene discussed is IL22RA2; the disease is psoriasis.